Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-10,899
Closed -$13K 518
2019
Q1
$13K Buy
+10,899
New +$815K ﹤0.01% 324
2018
Q4
Sell
-10,585
Closed -$132K 419
2018
Q3
$132K Buy
10,585
+1,572
+17% +$100K 0.01% 283
2018
Q2
$55K Buy
9,013
+3,773
+72% +$213K ﹤0.01% 386
2018
Q1
$272K Buy
5,240
+1,048
+25% +$56.6K ﹤0.01% 161
2017
Q4
$225K Buy
+4,192
New +$232K ﹤0.01% 259
2017
Q3
Sell
-18,235
Closed -$1.11M 275
2017
Q2
$1.11M Buy
18,235
+18,053
+9,919% +$1.1M 0.06% 161
2017
Q1
$1.11M Buy
+182
New +$11K 0.05% 124
2015
Q1
Sell
-59,317
Closed -$3K 421
2014
Q4
$3K Buy
+59,317
New +$3.3M ﹤0.01% 206

Other funds holding MRK

Cowen Inc's MRK Position: Q2 2019 in Review

Cowen Inc sold out of Merck (MRK) in Q2 2019, closing a stake of 2,096 shares — an estimated $166K sold.

Cowen Inc first reported a position in MRK in Q2 2013 and held it in 3 quarters. The position peaked at $4.48M in Q2 2013. 2,299 funds tracked by Wall St. Rank hold MRK as of Q2 2019.

  • Cowen Inc reported no remaining Merck position as of Q2 2019 after selling out during the quarter.
  • Cowen Inc sold 2,096 Merck shares in Q2 2019, an estimated $166K.
  • Cowen Inc first reported a position in Merck in Q2 2013 and held it in 3 quarters.
  • Cowen Inc's Merck position peaked at $4.48M in Q2 2013.
  • 2,299 funds tracked by Wall St. Rank held Merck as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.